期刊文献+

自建生化检测系统的量值溯源性和可比性研究 被引量:12

Study on the traceability and comparability of a self-developed biochemical testing system
下载PDF
导出
摘要 目的探讨实现自建生化检测系统量值溯源性和可比性的方法。方法以新鲜患者血清为临时校准品,在目标检测系统上定值后校准自建检测系统,校准验证有效后,在自建检测系统上对日常校准品进行定值,用新的校准值校准自建检测系统,经校准验证后,进行方法比对,评估自建检测系统与目标系统检测结果的偏倚是否在可接受范围内。结果自建检测系统Ⅰ与目标系统不具可比性的6个项目包括总胆红素(TBil)、直接胆红素(DBil)、γ-谷氨酰基转移酶(GGT)、三酰甘油(TG)、总钙(TCa2+)、无机磷(IP),自建检测系统Ⅱ与目标系统不具可比性的5个项目包括白蛋白(Alb)、TBil、DBil、TG、IP,经校准和校准验证后,与目标系统的偏倚均<1/2CLIA′88允许总误差(TEa),临床可以接受。结论校准和校准验证是实现自建检测系统量值溯源性和可比性的有效途径。 Objective To establish a method to achieve the traceability and comparability of a self-developed biochemical testing system. Methods The fresh serum of patients was adopted as temporary calibrator and assayed in objective testing system before it was applied to calibrate self-developed testing system. After successful calibration verification, daily calibrators were determined in self-developed system and attained a new calibration value. Then this value of calibrator was used to calibrate self-developed testing systems again. After effective verification, we evaluated the bias between self-developed system and objective system by comparative test, and decided that the bias was acceptable or not. Results The bias of six items with no comparability between self-developed systems Ⅰ and objective system, and the bias of five items with no comparability between self-developed system Ⅱ and objective system, after calibration and verification, all the bias were lower than half of CLIA'88 allowable total error. Conclusions The traceability and comparability of self-developed biochemical testing system can be achieved by calibration and verification.
出处 《检验医学》 CAS 北大核心 2007年第3期299-303,共5页 Laboratory Medicine
基金 国家"863"资助项目(2004AA2Z3762) 广东省医学科研基金立项课题(A2006252)
关键词 溯源性 可比性 检测系统 比对研究 Traceability Comparability Testing system Comparative study
  • 相关文献

参考文献6

二级参考文献13

  • 1李萍,刘小娟,徐克和,黄志刚.利用Westgard标准决定图判定测定方法性能[J].临床检验杂志,2006,24(1):69-70. 被引量:27
  • 2张秀明,庄俊华,徐宁,黄宪章,陈茶,尹一兵,梁伟雄.不同检测系统血清酶测定结果的偏倚评估与可比性研究[J].中华检验医学杂志,2006,29(4):346-349. 被引量:137
  • 3张秀明,郑松柏,孙蕾,柯培锋,马骥,张文,林莲英.应用Westgard方法评价决定图判断生化检测系统性能的可接受性[J].中华检验医学杂志,2007,30(1):86-90. 被引量:73
  • 4International Organization for Standardization.General Requirements for the Competence of Testing and Calibration Laboratories.ISO/IEC 17025,International Organization for Standardization,Geneva,1999.
  • 5The National Committee for Clinical Laboratory Standards.Method Comparison and Bias Estimation Using Patient Samples.Approved Guideline,Second Edition,EP9-A2,2002.
  • 6Siekmann L,Bonora R,Burtis CA,et al.IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 degrees C.International Federation of Clinical Chemistry and Laboratory Medicine.Part 7.Certification of four reference materials for the determination of enzymatic activity of gamma-glutamyltransferase,lactate dehydrogenase,alanine aminotransferase and creatine kinase accord.Clin Chem Lab Med,2002,40:739-745.
  • 7Westgard JO.A method evaluation decision chart (MEDx Chart)for judging method performance.Clin Lab Sci,1995,8:277-283.
  • 8Ricos C,Alvarez V,Cava F,et al.Current databases on biological variation:pros,cons and progress.Scand J Clin Lab Invest,1999,59:491-500.
  • 9Westgard JO,Burnett RW.Precision requirements for costeffective operation of analytical processes.Clin Chem,1990,36:1629-1632.
  • 10National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patient samples[S].Approved Guideline,2nd ed,EP9-A2,2002.

共引文献266

同被引文献78

引证文献12

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部